Clinical trials: Blood Glucose Monitoring
Blood Glucose Monitoring
How Does YES Bar Affect Blood Glucose Levels?
Curious to see if there is a sweet treat that doesn't spike your blood sugar (avoiding the energy crash, inflammation, and weight gain)? This study uses the Abbott Lingo CGM to see how your blood glucose levels responds to YES…
- Trial name
- NCT07256652
- Testing
- YES Bar
- Where
- United States
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- Efforia, Inc
Metabolic Syndrome, Obesity & Overweight
Evaluating the SWW Method Dietary Intervention for HbA1c and Weight Management as a Preventative Intervention in Women
This study evaluated the SWW Method®, a 12-week dietary and lifestyle intervention based on the carbohydrate-insulin model, in a healthy cohort of women aged 35-75.
- Conditions
- Metabolic Syndrome, Obesity & Overweight, Blood Glucose Monitoring, Type 2 Diabetes Prevention
- Trial name
- NCT07463417
- Testing
- SWW Method® Dietary and Lifestyle Intervention
- Where
- United States
- Volunteers
- 85 people, healthy volunteers welcome
- Sponsor
- Sarah Wragge Wellness
Intensive Care Unit Blood Glucose Monitoring
GlucoClear ICU Study
The primary purpose of this Study is evaluation of the safety and accuracy of the GlucoClear CGM System.
- Trial name
- NCT02238041
- Testing
- GlucoClear System
- Sponsor
- Edwards Lifesciences
ICU/CCU Patients Requiring Blood Glucose Monitoring
MANAGE Automated Glucose Monitoring
The objective of this study is to demonstrate that the OptiScanner® is safe and can provide accurate blood glucose levels in critically ill subjects.
- Trial name
- MANAGE IDE (NCT02211300)
- Testing
- The OptiScanner, YSI 2300 STAT Plus™
- Where
- 4 sites in United States
- Volunteers
- 230 people
- Sponsor
- OptiScan Biomedical Corporation
Blood Glucose Monitoring in Medical ICU
Comparative Study of GlySure Continuous Intra-vascular Glucose Monitoring and Intermittent Monitoring in Medical ICU
It has been shown that close control of blood glucose levels in the intensive care unit patient has benefits for patient morbidity and mortality rates as well as an impact upon discharge times.
- Trial name
- MICU (NCT02142088)
- Testing
- GlySure Intravascular Continuous glucose monitoring sensor
- Volunteers
- 60 people
- Sponsor
- GlySure
Accurate Blood Glucose Monitoring in Critical Care Setting
GlucoClearTM System ICU Study
The primary purpose of this Study is evaluation of the safety and performance of the GlucoClear System (System). The primary safety objective will be assessed by: Evaluation of any serious adverse device effects upon Sensor…
- Trial name
- NCT02094859
- Where
- 2 sites in Austria, Belgium
- Volunteers
- 50 people
- Sponsor
- Edwards Lifesciences